Sleep onset — GABAergic & sedative
One of 4 mechanistic pathways to 🌙 Sleep better · 17 options
Falling asleep requires the inhibitory system to overcome the arousal system. These act on GABA-A or on histamine to tip that balance. They work on onset and mostly do nothing for depth — and the strong ones buy onset at the cost of slow-wave and REM.
If you cannot fall asleep, check whether something is keeping you awake before you sedate on top of it. High evening cortisol and an overactive thyroid both do this.
Magnesium, RBCCortisol (AM)TSH (Thyroid-Stimulating Hormone)Free T3 (Triiodothyronine)😴 Sleep Quality & Recovery covers these in one panel →
What engages this pathway
Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.
🧬 Glycine
3 g before bed lowers core body temperature via peripheral vasodilation, which is the physiological trigger for sleep onset. Japanese trials show faster onset and better next-day alertness — and it does not sedate, which is the elegant part.
🧬 Magnesium L-Threonate
Raises brain magnesium specifically; magnesium modulates both NMDA and GABA-A.
🧬 Magnesium
Bisglycinate is the form for this — the glycine carrier contributes its own effect, so you get two mechanisms.
🧬 L-Theanine
Reduces sleep-onset latency by lowering pre-sleep arousal rather than by sedating.
🧬 Apigenin
Binds the benzodiazepine site on GABA-A weakly. The active behind chamomile's reputation.
🧬 Chamomile (Apigenin-standardized)
Standardized extract improved sleep quality in older adults in a randomized trial.
🧬 Valerian
GABA-A modulation with meta-analysis support for subjective sleep quality. Effect builds over weeks rather than on night one.
🧬 Passionflower
A modest but real improvement in sleep quality in a polysomnography-controlled trial.
🧬 Hops
Traditionally paired with valerian, and the combination has better trial data than valerian alone.
🧬 Magnolia Bark
Honokiol is a defined GABA-A modulator with a real receptor mechanism behind the herbal label.
🧬 Lemon Balm
GABA transaminase inhibition. Gentle, and best combined.
🧬 Deep Sleep Complex
A botanical-plus-melatonin blend covering onset and rhythm together.
🧬 Sleep Stack
Bundled approach across onset and depth.
💉 Phenibut
GABA-B agonism produces reliable sleep and equally reliable tolerance — within about two weeks of nightly use you need more, and stopping produces a withdrawal syndrome that has required hospitalization. Not a sleep aid.
💉 Doxepin
At 3–6 mg it is a pure H1 antagonist and works on sleep MAINTENANCE rather than onset, without the tolerance profile of hypnotics. One of the better-reasoned pharmacological options.
💉 Trazodone
Low-dose 5-HT2A and H1 antagonism. Widely used off-label for sleep; next-day grogginess and, rarely, priapism are the real costs.
💉 Cyclobenzaprine
A muscle relaxant structurally related to tricyclics. Used where pain or spasm is what's breaking the sleep, not as a primary hypnotic.
What actually decides this outcome, in order of size
Everything on this page is dosed against a number almost nobody in the readership has ever written down. Ranked by how much of the outcome each one owns:
- Your actual sleep-onset latency, measured over a fortnight. Clinical insomnia criteria use a threshold of roughly 30 minutes to fall asleep, occurring most nights and causing daytime consequences. A 20-minute latency is normal physiology and is not shortenable by anything on this shelf. Two weeks of a written diary decides whether this page has a target, and it is free.
- Whether the problem is onset or phase, because they look identical from the inside. Somebody whose circadian clock is set two hours late is not failing to fall asleep, they are lying in bed during their biological evening. The same complaint, an entirely different intervention, and no GABAergic agent fixes it.
- That the first-line treatment for chronic insomnia is behavioral rather than pharmacological. National guidance for insomnia in adults places cognitive behavioral therapy first Drager 2023, and it improved sleep in insomnia comorbid with psychiatric and medical conditions in a meta-analysis Wu 2015. That is a stronger evidence base than any product on this page and it is not for sale here.
- Whether something is generating arousal that no sedative will outcompete. Alcohol, an untreated pain problem, restless legs from iron deficiency, an evening stimulant, or a bedroom that is too warm. Each of these produces onset difficulty and each is cheaper to remove than to sedate.
- The compounds, last, and the honest summary of the botanical arm is that the trials are small and the quality is mixed. Valerian's systematic review and meta-analysis found exactly that Bent 2006, and the best single comparison put a valerian-hops combination against diphenhydramine Morin 2005.
The order to run these in, and what has to be true first
Diary first, imitators second, botanicals third, and the prescription sedatives last and through a prescriber. Running this backwards is how somebody arrives at a dependence problem for a latency that was never abnormal.
- Fourteen nights of a sleep diary before anything is bought. Lights out, estimated latency, awakenings, final wake time. That record is the diagnostic instrument the guidelines are built on Drager 2023, and it also identifies the reader whose real problem is time in bed rather than time to sleep.
- One draw for the imitators. Ferritin because restless legs is an iron-responsive cause of onset difficulty at ferritin values a full blood count will not flag. TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine) because thyrotoxicosis presents as insomnia with palpitations. HbA1c (Hemoglobin A1c) and Comprehensive Metabolic Panel (CMP) if nocturia is part of the picture.
- Magnesium first among the supplements, with the population attached. The systematic review is in older adults with insomnia Mah 2021, and magnesium is also the cheapest item here. Magnesium L-Threonate is a different salt sold on a central-distribution argument rather than on that review.
- Glycine and L-Theanine next, on small human literatures and a thermoregulatory mechanism. Both are proposed to act by lowering arousal rather than by sedating, which is why they do not produce next-morning impairment and also why their effect sizes are modest.
- Valerian, Hops and the combination products, judged on the trial rather than the tradition. Bent 2006 is the pooled position and Morin 2005 is the head-to-head. Humulone from hops modulates GABA-A receptors, which is the mechanism behind the sedative reputation of the plant Benkherouf 2020. Deep Sleep Complex and Sleep Stack are blends of these and are judged on their components.
- Chamomile (Apigenin-standardized) and Apigenin are one argument, not two. Apigenin is chamomile's active flavonoid and binds the benzodiazepine site of the GABA-A receptor without the full agonist profile Avallone 2000. The catch is exposure: apigenin's bioavailability from a food matrix has been measured and it is low Meyer 2006. A randomized trial of oral chamomile extract exists in generalized anxiety rather than in insomnia Amsterdam 2009.
- Passionflower, Lemon Balm and Magnolia Bark are the tail of the botanical arm. Each has a plausible GABAergic mechanism and a thinner trial base than valerian, which already has a thin one.
- Doxepin, Trazodone, Cyclobenzaprine and Phenibut are pharmacology and three of the four need a prescriber. Doxepin at milligram doses is a selective histamine H1 antagonist studied in elderly patients with primary insomnia Scharf 2008, which is a different drug from the same molecule at antidepressant doses. Phenibut is the one item here with published dependence and withdrawal case reports Ahuja 2018 and it is the one most likely to be bought without anybody knowing.
What gets bought for this that cannot move it
The category that fails structurally is the sedative bought for a normal latency. A GABA-A positive modulator shortens the time to sleep onset from an abnormal value; it cannot shorten a 15-minute latency to zero, because the remaining time is the descent itself. That is why the honest first step on this page is a diary and not a purchase, and why the guideline answer to persistent insomnia is behavioral Drager 2023 Wu 2015.
The strong ones buy onset and sell architecture, which the page's own introduction says and then does not price. Sedation is not sleep. An agent that produces unconsciousness faster while suppressing slow-wave and REM sleep leaves the reader with a shorter latency and a worse night, and the subjective experience is of a product that works. The safest items on this page are the weak ones, and that is not a coincidence.
Phenibut is the option here whose risk most exceeds its reputation. It is sold as a calming supplement and it produces a withdrawal syndrome documented in the case literature Ahuja 2018. Tolerance develops quickly, the dose escalates, and the escalation is invisible because nobody is supervising it. Valerian has a much smaller version of the same story in a published hepatotoxicity case Cohen 2008, which is the reason a botanical is not automatically the safe choice.
And if the shape of the night is different, so is the page. Falling asleep easily and waking at three is Sleep depth, slow-wave & recovery quality. Not sleepy until 2 am and fine if allowed to wake late is Circadian & melatonergic rhythm. Racing thoughts and daytime worry is GABAergic & calming. Snoring with witnessed pauses is a sleep study, and sedating that reader is the one genuinely dangerous action available from this page.
How you would know it was working, on a real read-out and a real timescale
This page makes a prediction with a number in it. If a GABAergic agent is doing the work, diary-recorded sleep latency should fall by a clinically obvious margin within two weeks and stay down, while total sleep time and morning alertness do not deteriorate. If latency falls and daytime function gets worse, the product bought unconsciousness rather than sleep.
- A written diary, nightly, for 14 nights before and 14 after. Latency, awakenings and a morning alertness rating. This is the primary read-out because it is the instrument the guidelines use Drager 2023 and because no blood test measures sleep onset.
- Ferritin once, and again at 12 weeks if it was low and is being treated. Restless legs responds to iron repletion at ferritin values inside the printed reference range, so a normal-looking result is not the end of the question. Twelve weeks because that is roughly a red cell cohort's lifespan.
- TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine) once, to be normal. Thyrotoxicosis is an uncommon but entirely reversible cause of onset insomnia, and finding it here saves years of sedatives.
- Comprehensive Metabolic Panel (CMP) before and during any prescription sedative. Hepatic handling matters for doxepin and trazodone, and the valerian hepatotoxicity case is the reason a botanical does not exempt anybody from this Cohen 2008.
- 2 weeks for a verdict on a sedative, 4 on a botanical. Two because a GABA-A modulator acts on the night it is taken, so anything that has not worked in fourteen nights will not start. Four for the botanicals because the trials that support them ran on that order of time Bent 2006.
What will fool you. Sleep latency is systematically over-estimated by people who are not sleeping, so the improvement in the diary is partly an improvement in attention to the diary. Anything started in a bad fortnight improves, because bad fortnights end. Next-morning sedation feels like a deeper sleep and is the opposite of one, which is why the alertness rating belongs beside the latency. A wearable's sleep-onset time is a movement model, not a measurement. And apigenin's absorption from a food matrix is low Meyer 2006, so two chamomile products at the same labeled milligrams are not the same exposure.
Sources read for these sections
- Drager LF. 2023 Guidelines on the Diagnosis and Treatment of Insomnia in Adults - Brazilian Sleep Association. Sleep Science 2023 · PMID 38370879
- Wu JQ, et al. Cognitive Behavioral Therapy for Insomnia Comorbid With Psychiatric and Medical Conditions: A Meta-analysis. JAMA Internal Medicine 2015;175(9):1461-72 · PMID 26147487
- Bent S, Padula A, et al. Valerian for sleep: a systematic review and meta-analysis. American Journal of Medicine 2006 · PMID 17145239
- Morin CM, et al. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial.. Sleep 2005 · PMID 16335333
- Amsterdam JD, Li Y, et al. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. Journal of Clinical Psychopharmacology 2009 · PMID 19593179
- Avallone R, et al. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochemical Pharmacology 2000 · PMID 10751547
- Meyer H, Bolarinwa A, et al. Bioavailability of apigenin from apiin-rich parsley in humans. Annals of Nutrition and Metabolism 2006 · PMID 16407641
- Benkherouf AY, et al. Humulone Modulation of GABAA Receptors and Its Role in Hops Sleep-Promoting Activity. Frontiers in Neuroscience 2020 · PMID 33177986
- Mah J. Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis. BMC Complementary Medicine and Therapies 2021;21(1):125 · PMID 33865376
- Ahuja T, et al. Phenibut (beta-Phenyl-gamma-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse. Case Reports in Psychiatry 2018 · PMID 29854531
- Scharf M. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.. J Clin Psychiatry 2008 · PMID 19192438
- Cohen DL, Del Toro Y. A case of valerian-associated hepatotoxicity. Journal of Clinical Gastroenterology 2008 · PMID 18431248
The other 3 routes to sleep better
Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.
You know the goal. Skool has the plan.
This pathway is one arm of The Sleep better Blueprint. The members' version has where this arm sits in the sequence, what to stack it with, and the markers that tell you to keep going or stop.
Open The Sleep better Blueprint in Skool →$10/mo, cancel anytime.
← Open this pathway in the interactive Vault
Frequently asked questions
Falling asleep requires the inhibitory system to overcome the arousal system. These act on GABA-A or on histamine to tip that balance. They work on onset and mostly do nothing for depth — and the strong ones buy onset at the cost of slow-wave and REM.
17 options are mapped to this pathway in the Vault, including Glycine, Magnesium L-Threonate, Magnesium, L-Theanine. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 14 carry clinical validation and 3 are mechanistic predictions.
If you cannot fall asleep, check whether something is keeping you awake before you sedate on top of it. High evening cortisol and an overactive thyroid both do this. The markers worth checking are Magnesium, RBC, Cortisol (AM), TSH (Thyroid-Stimulating Hormone), Free T3 (Triiodothyronine).
Unproven is not the same as ineffective. Of the 17 options on this pathway, 14 have clinical validation and 3 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.
Where this goes next
Everything above is the free case for Sleep onset — GABAergic & sedative. The protocol — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.